Vetter has introduced two clinical syringe packages designed to make it easier to begin syringe development earlier in the drug development process, with the goal of cutting time-to-market. The self-contained, modular packages are designed to provide a clear roadmap through the syringe development process.
The company’s Clinical Syringe Standard Package includes all development activities through launch, beginning with materials selection through cGMP clinical syringe filling. The Clinical Syringe Starter Package offers a range of feasibility testing without the financial commitment to a clinical fill, beginning with the same materials selection, proceeding through feasibility testing and regulatory consultation, and ending with a non-cGMP stability run.
“As the market moves toward prefilled syringes,” said Vetter managing director Peter Soelkner, “We wanted to enable our customers to get an earlier start on syringe development, when it suits their compound and their business goals. Our new clinical syringe packages, coupled with the development expertise of our scientists and the advanced technology of our facilities, give our customers an easier way to pursue syringe work earlier.”